Damsin (1) is a natural pseudoguaianolide sesquiterpene that inhibits NF-κB, a protein complex that controls the transcription of DNA in mammalian cells, and has a potential for standing model for the development of new anti-cancer lead structures. In order to do a preliminary structure-activity study and improve the anti-cancer activity, fourteen derivatives and analogs were prepared and evaluated. These were chosen to represent both structural diversity and structural novelty. The importance of α methylene-γ-lactone moiety for the anti-cancer activity was confirmed, even though other features in the scaffold were shown to be important for the activity. In some cases a new substitution negatively affected the initial activity, however, two analogues, indolo [3,2-c]-4-desoxydamsin (5) and ambrosin (6), were found to be more potent.
Introduction
NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells, is a family of protein complexes that control the transcription of DNA as transcription factors. They are involved in the cellular responses to various stimuli, an important part of the immune system and responsible for cytokine production and cell survival. Poor Scheme 1. Sesquiterpenes with an α-methylene-γ-lactone moiety.
Results
Damsin (1) and coronopilin (2) are known pseudoguaiane sesquitepenes that can be isolated from Ambrosia arborescens Mill. [34] [36] . As the isolation of 1 in larger amounts was achievable, it was selected as the starting material for all the chemical modifications. Our ambition was not only to modify the Michael acceptor moiety and consequently the reactivity, but also to introduce new groups into the pseudoguaiane skeleton in order to investigate the effect of non-covalent interactions. The compounds prepared can be divided in three categories (Scheme 1): Group A, compounds retaining the α-methylene-γ-lactone moiety; Group B, compounds with a modified Michael acceptor in the γ-lactone moiety and Group C, compounds lacking a carbon-carbon double bond in the γ-lactone ring.
Group A. New hydrogen donors/acceptors in 1 were introduced in compounds 3 and 4. A Rubottom oxidation provided 3 that is hydroxylated in position 3 (Scheme 1) [42] , while a selective reduction of the keto function through a Luche reduction with NaBH 4 in presence of CeCl 3 afforded 4 [43] . A Fischer indole synthesis with phenylhydrazine gave 5 that has a planar and rigid structure. To avoid competitive reactions of the hydrazine with the α methylene-γ-lactone moiety, the thiophenoxide-protected adduct (17) was used as starting material (Scheme 2(a)). The molecule was deprotected by a selective oxidation of the thioether to a sulfoxide with m-CPBA at −20˚C, followed by a thermal elimination. Ambrosin (6) , a natural product, was prepared via a Saegusa-Ito oxidation [42] . 6 is unique in this investigation by containing a second Michael acceptor function. Group B. The isomerization of 1 to 7 was achieved by treatment with RhCl 3 [42] , providing a derivative that still is a Michael acceptor but less available for nucleophilic attack and consequently less reactive [40] . 8 was designed to facilitate a Michael addition by providing an intramolecular basic catalysis for an incoming thiol [44] . Several strategies towards 8 were investigated, including metathesis and a Wittig olefination reaction, but the procedure that eventually succeeded (see Scheme 2(b)) starts with a Michael addition of a cyanide ion to the acetal 20 to give the nitrile 21. After the reduction of 21 to the tertiary amine 22 and the oxidation of the lactone ring of 22 via the bromine 23 to the olefine 24. Finally, 8 was obtained by the hydrolysis of the acetal protection group. Compound 9 was prepared from 7 by a procedure similar to the Rubotton oxidation [45] . Firstly, 7 was protected as the acetal 25, which wasoxidized to 27 via the 2-hydroxyfuran silylether 26 (not isolated), and finally deprotected by hydrolysis to yield 9 (Scheme 2(c)). Compound 10 was prepared from 1 by a Heck coupling reaction, following procedures reported for α-methylene-γ-lactones [46] [47] . However, the isomerization could not be avoided, yielding the endocyclic α, β-unsaturated-γ-lactone 10.
Group C. Even though it has been stated that the absence of the α-methylene-γ-lactone moiety renders this class of terpenes inactive as inhibitors of NF-κB [29] , we wanted to include also such compounds in this investigation. The reduction of the α-methylene-γ-lactone of 1 with NaBH 4 gave the two epimers 11 and 12 [42] . The Claisen-Schmidt condensation of 1 with benzaldehyde in ethanol gave 13 [48] . The hydroxylated compound 14 was prepared following an iterative procedure [49] with the hydrogen peroxide and catalyst 16 (Scheme 2). Although this catalyst hydroxylated the desired tertiary position, the epoxidation of the double bond was unavoidable. Finally, the reaction of 1 with dimethyl amine in ethanol yielded the amine adduct 15 (as an epimeric mixture 3:1 11α:11β) [50] , for evaluation of its possible usefulness as a pro-drug.
The configuration of the products and intermediates was determined by comparing the 1 H NMR coupling constants and correlations observed in the NOESY spectra, with computational models. The conformational search was carried out using the MMFFs force field and the low energy conformers were optimized using B3LYP/6-31G** basis set. In several cases a second order system was resolved in order to determine the coupling constants, and this was done by approximation using spin simulation. For compound 4, for example, the coupling constants and atomic distances of the 4β-hydroxyl group were experimentally and computationally correlated as follows. While the experimental coupling constants of H-4α with H-3α and H-3β both are 9.0 Hz, the calculated coupling constants were 8.0 Hz for H-3α and 8.1 Hz for H-3β. In addition, a NOESY correlations was observed from H-4α toH-1, corresponding with the calculated distance (2.40 Å), as well as to H-6 (calculated distance 2.26 Å). The chiral centers as well as the double bond configurations were assigned in the corresponding way for all the derivatives. The structural elucidation of 3, 11 and 12 has previously been reported by us [42] .
The coupling constants and atomic distances of each compound with a new chiral center are experimentally and computationally consistent as follows:
Compound 9. A NOE correlation was observed between OH-6 and H-1, corresponding with the calculated distance of 3.04 Å.
Compound 13. The configuration of C-11 was assigned considering the experimental coupling constant of H-11β with H-7α (7.2 Hz), compared with the calculated coupling constant (11.9 Hz) . In addition, NOESY correlations were observed between H-11β andH 3 -15, H-8α, H-8β and H-9β corresponding to the calculated interatomic distances 2.36, 3.01, 3.86 and 2.16 Å, respectively. NOESY correlations between H 2 -13 to-OCH 2 CH 3 (weak), H-7, -OCH 2 CH 3 and H-6 correspond to the interatomic distances 4.60, 2.70, 2.40 and 2.54 Å, respectively. A second order system (ABM) was resolved for H-13a and H-13b, to discriminate their coupling constants with H-11β. The error is small enough to confirm the proposed stereochemistry, even though the contribution of more than one conformer could explain the divergence. In addition the E isomerism of the 3-phenylethenyl, was confirmed trough NOE correlations of H-2' with H-2a and H-2b (2.224 Å and 2.449 Å, respectively).
Compound 15. The relative amounts of the two diastereomers in the epimeric mixture obtained was made using the integral of H-6 for each epimer. The complete assignation was done by a careful analysis of the 2D spectra. The configuration of C-11 in the two epimers was determined by the NOESY correlation observed between H-11 andH 3 -15 in the spectrum of the major epimer (11β, 13-dihydro-13-(N, N-dimethylamino) damsin)),and the correlation between H-11 and H-6 for the minor epimer (11α, 13-dihydro-13-(N, N-dimethylamino) damsin.
Compound 17. The configuration of C-11 in 17 was suggested by the experimental coupling constant between H-11β and H-7 (7.7 Hz) compared with the calculated coupling constant (11.4 Hz) . This was confirmed by the NOESY correlations between H-11β and H-8β (weak), H-9β and H 3 -15 corresponding to the interatomic distances 3.01, 2.23 and 2.37 Å, respectively.
Compound 18. The configuration of C-11 in 17 was suggested by the experimental coupling constant between H-11α and H-7(6.0 Hz) compared with the calculated coupling constant (6.4 Hz) . A second order system (AMNX) was resolved for H-11α, H-7, H-13a and H-13b, in order to determine their coupling constants and chemical shifts. In addition, a NOESY correlation was observed between H-11α and H-6 corresponding to the interatomic distance of 2.51 Å.
Compound 22. NOESY correlations were observed between H-11β and H-8β as well as H 3 -15, corresponding with the calculated distance of 2.42 and 2.44 Å, respectively.
NF-κB Inhibition and Structure Activity Relationship
To analyze the NF-κB inhibitory activity of the synthesized compounds we used the stably transfected cell line 5.1, a lymphoid T cell line in which the HIV-1 LTR is activated by TNF-α through an NF-κB dependent mechanism [51] . The HIV-1 LTR promoter contains two κB sites that are critically required to respond to TNFα, and it is well known that deletion of the two κB sites in the LTR promoter abolishes completely the response to TNFα. Thus, 5.1 cells represent an excellent cellular model for the screening of anti-NF-κB compounds. We have previously found that dasmin (1) and coronofilin (2) possess anti-NF-κB activity, with IC 50 values of 7.2 and 10.1 µM respectively [35] . As shown in Table 1 , two compounds from group A (5 and 6) have a lower IC 50 value compared to 1, suggesting that indolic system slightly favors the ability of the compound to interact On the other hand, compounds 2, 3 and 4 still possess theoriginal α-methylene-γ-lactone but are less potent (especially 3 and 4) compared to 1. These results strongly indicate that a number of intermolecular interactions between the compound assayed and the protein it affects modulate their effects, and that a more systematic QSAR study to understand such interactions in detail is motivated. The compounds in group B possess a modified α-methylene-γ-lactone moiety. Compound 7 is inactive at the maximal concentration tested, which could be explained by the lower reactivityof the endocyclic α, β-unsaturated-γ-lactone moiety and its inability to form stable adducts with thiols [53] . However, compound 8 is also inactive although it was designed to provide support for a thiol attacking C-13. Possibly the steric hindrance posed by the C-13 substituent prevents an attack. Compound 9 is an interesting exception with an intermediate activity, possibly caused by a hydrolysis of the hemi-acetal lactonic ring forming a 1,4-enedione with a higher reactivity. Compound 10 is less potent, but the comparison with 7 and indicates that the aromatic group in position 13 slightly enhance the ability of the compound with the protein.
The compounds of group C as 11 and 12 are inactive as was predictable, confirming the crucial role of the α-methylene-γ-lactone moiety for the inhibition of NF-κB [23] . The inactivity of compound 14 demonstrate that other electrophilic groups, such as an epoxide, in positions 11, 13 can not replace the α-methylene-γ-lactone moiety, even though the position is the same. Compounds 13 and 15 are weakly active, this could be explained ifthe Michael addition of etoxide and dimethyl amine to the α-methylene-γ-lactone moiety is reversible but this was not further investigated. Amines like 15 are classical pro-drugsof sesquiterpene lactones [18] [40] [50] , although 15 is considerably less activecompared todamsin (1) in this study.
Conclusion
In total, fourteen derivatives were prepared, characterized and assayed. Several (7, 8, 11, 12 and 14) were inactive at the tested concentrations, confirming the importance of the α-methylene-γ-lactone moiety for the activity. Nevertheless, compound 10 is slightly active, suggesting that also endocyclic Michael acceptors may be active and that an aromatic group in position 13 can be important. Also, compound 9 was unexpectedly active, probably because the hemi-acetal can be hydrolyzed to a more reactive 1,4-enedione. The compounds 2, 3 and 4 are somewhat surprisingly less active compared to 1, indicating that hydroxyl groups on positions 1, 3 or 4, respectively, have a negative effect on the ability of the sesquiterpene to interact with the protein. For compound 15, the ability to regenerate the α-methylene-γ-lactone moiety during the performance of the assay is the probable reason for its modest activity, amine adducts (15) have previously been demonstrated to possess such a reversibility [50] . This is not the case for ethers, e.g. 13, so there may be another reason for its modest activity. Finally, compounds 5 and 6 are more potent compared to 1. This was expected for 6 as it possesses two Michael acceptors, but unexpected for 5. Possible explainations are that the indol system imposes a steric strain on the molecule, including the α-methylene-γ-lactone moiety, which could be relieved if C-11 no longer is part of an unsaturation. Alternatively the indole may be involved in some specific interaction with the molecular environment of the reacting cysteine, favoring the position of the α-methylene-γ-lactone moiety in the right place. The need for a more systematic investigation is evident. 4β-hydroxy-4-deoxydamsin (4) . To a solution of 1 (100 mg, 0.4027 mmol) and CeCl 3 ·7H 2 O (150.0 mg, 0.4027 mmol) in MeOH (2.5 mL), was added NaBH 4 (15.2 mg, 0.4027 mmol) in one portion. The reaction mixture was stirred at room temperature for 40 min and then quenched with a 10% HCl solution (1 mL). The mixture was neutralized with NaHCO 3 sat. (pH = 7) and the aqueous mixture was extracted with DCM (4 × 10 mL). The combined organic layers were dried with Na 2 SO 4 and concentrated in vacuo to give the crude product, which was purified by silicagel flash chromatography (30% EtOAc: Pet. Et. 11β,13-dihydro-13-thiophenoxydamsin (17) and 11α,13-dihydro-13-thiophenoxydamsin (18) . PhSH (300 μL, 2.9409 mmol) was carefully added to metallic sodium (28.0 mg, 1.2080 mmol) and when the reaction was complete, EtOH was added (1 mL) and the solution was stirred at room temperature for 1 h. Then, a solution of 1 (100 mg, 0.4027 mmol) in ethanol (2.5 mL) was added and the reaction was stirred at room temperature for 1 h. The reaction was quenched with 4 drops of AcOH, followed by 2 mL of water. The aqueous phase was extracted with DCM (3 × 10 mL), the combined organic layers were dried with Na 2 SO 4 and concentrated in vacuo to give the crude product, which was purified by silicagel flash chromatography (from 15% to 25% EtOAc:Pet. Et. ) to provide the product 17 (74.6 mg, 52% 1H, m, H-1), δ 1.82 (1H, m, H-2a), δ 2.07 (1H, m, H-2b), δ 2.12 (1H, m, H-3a), δ 2.46 (1H, m, H-3b) Indolo[3,2-c]-13-thiophenoxy-11b,13-dihydro-4-deoxydamsin (19) . To a solution of 17 (189.5 mg, 0.5286 mmol) in AcOH (8 mL) was added phenylhydrazine (396 μL, 6.4086 mmol) and the reaction was stirred in a reflux system for 1 day at 120˚C. After that, 3 additional portion of phenylhydrazine (58 μL, 0.5894 mmol) were added, one per day. After a total reaction time of 4 days, the reaction was quenched with sat. Na 2 CO 3 solution (100 mL) until pH = 8 and the aqueous mixture was extracted with DCM (5 × 30 mL). The combined organic layers were washed with brine, dried with Na 2 SO 4 and concentrated in vacuo to give the crude product, which was purified by silicagel flash chromatography (from 10% to 20% EtOAc:Pet.Et. 
Experimental a) Chemistry
) δ 1.67 (1H, m, H-1), δ 1.52 (1H, m, H-2a), δ 1.80 (1H, m, H-2b), δ 1.53 (1H, m, H-3a), δ 2.05 (1H, m, H-3b), δ 3.99 (1H, t, 3 J 9.0; 9.0 Hz, H-4), δ 4.48 (1H, d, 3 J 9.5 Hz, H6), δ 3.34 (1H, m, H-7), δ 1.90 (1H, m, H-8a), δ 2.11 (1H, m, H-8b), δ 1.56 (1H, m, H-9a), δ 1.85 (1H, m, H-9b), δ 2.08 (1H, m, H-10), δ 5.49 (1H, d, 3 J 3.8 Hz, H-13a), δ 6.19 (1H, d, 3 J 3.5 Hz, H-13b), δ 1.01 (3H, d,
Indolo[3,2-c]-4-deoxydamsin(5).
To a solution of 19 (130.1 mg, 0.3014 mmol) in DCM (4 mL) was added m-CPBA 77% (67.5 mg, 0.3014 mmol) and the reaction was stirred at −40˚C. After 3 h, the reaction was quenched with sat. NaHCO 3 solution (2 mL) and extracted with DCM (3 × 10 mL). The combined organic layers were washed with brine (20 mL), dried with Na 2 SO 4 and concentrated in vacuo to give the crude product. Then, it was suspended in PhMe (20 mL) and the suspension was stirred in a reflux system at 110˚C for 3.5 h. The reaction was quenched allowing to reach room temperature and the solvent was evaporated in vacuo. The product was purified by silicagel flash chromatography (15% EtOAc:Pet.Et. ) to provide the product 5 (64.1 mg, 66% 3 .6243 mmol). The reaction was stirred at room temperature for 24 h. After that, it was quenched with a sat. NaHCO 3 solution (5 mL), then 10 mL of brine were added and the aqueous layer was extracted with DCM (3 × 15 mL). The combined organic layers were dried with Na 2 SO 4 and concentrated in vacuo to give the crude product, which was purified by silicagel flash chromatography (20% EtOAc:Pet. Et. 1H, m, H-1), δ 1.58 (1H, m, H-2a), δ 1.76 (1H, m, H-2b), δ 1.73 (1H, m, H-3a), δ 1.90 (1H,  m, H-3b), δ 4.95 (1H, d, 
3
J 9.5 Hz, H-6), δ 3.32 (1H, m, H-7), δ 1.87 (1H, m, H-8a), δ 2.02 (1H, m, H-8b), δ 1.58  (1H, m, H-9a), δ 1.86 (1H, m, H-9b), δ 2.07 (1H, m, H-10 (21) . To a solution of 20 (60.8 mg, 0.2081 mmol) and cynohydrin (76.0 μL, 0.8324 mmol) in DMSO (2 mL) was added NaCN (5.0 mg, 0.1020 mmol), and reaction was stirred in a reflux system at 30˚C. After 3.5 h, the reaction was quenched with a sat. NH 4 Cl solution (10 mL), extracted with EtOAc (3 × 10 mL), then the combined organic layers were dried with Na 2 SO 4 and concentrated in vacuo to give the crude product, which was purified by silicagel flash chromatography (20% EtOAc:Pet.Et. ) to provide the product 21 (58.1 mg, 87% 4,4-(ethylenedioxy)-11b,13-dihydro-13-(N,N-dimethylaminomethyl) -4-deoxydamsin (22) . A solution of 21 (645 mg, 2.0194 mmol), Pd-C 10% (193.0 mg) and Me 2 NH (5.9 mL, 33.0400 mmol, sol. ~5.6 M/EtOH) in EtOH (50 mL), was stirred in an autoclave under H 2 (400 psi) at room temperature for 6 days. Additional Pd-C (100 mg) was added and the reaction was completed after one more day. The reaction mixture was filtered trough celite, then the pad was washed with EtOH (2 × 10 mL) and the combined alcoholic extracts were concentrated in vacuo to give the crude product, which was purified by silicagel flash chromatography [2% (10% NH 4 11b-bromo-4,4-(ethylenedioxy)-13-hydro-13-(N,N-dimethylaminomethyl)-4-deoxydamsin (23) . To a solution of 22 (56.9 mg, 0.1620 mmol) and dry Et 3 N (135.1 μL, 0.9720mmol) in dry DCM (1.8 mL), was added TMSOTf (93.9 μL, 0.4860 mmol) and the mixture was stirred at 0˚C for 2 h. Then, TMPAP (182.7 mg, 0.4860 mmol) was added as solution in dry DCM (2.5 mL) and the reaction was stirred at 0˚C for exactly 1.75 h. The reaction was quenched with a 10% Na 2 S 2 O 3 sol. (10 mL) and sat. NaHCO 3 solution (10 mL), extracted with DCM (4 × 10 mL), whereafter the combined organic layers were dried with Na 2 SO 4 and concentrated in vacuo to give the crude product, which was purified by silicagel flash chromatography [from 1% to 3% (10% NH 4 1H, m, H-8a), δ 1.58 (1H, m, H-8b), δ 1.54 (1H, m, H-9a), δ 1.81 (1H, m, H-9b), δ 2.01 (1H, m, H-10 1 (C-1), 23.3 (C-2), 31.1 (C-3), 119.8 (C-4), 51.1 (C-5) , 79.8 (C-6), 56.1 (C-7), 19.9 (C-8), 36.8 (C-9), 34.4 (C-10), 64.7 (C-11), 173.6 (C-12), 32.1 (C-13), 16.1 (C-14) (E)-4,4-(ethylenedioxy)-13-(N,N-dimethylaminomethyl)-4-deoxydamsin (24) . To a solution of 23 (157.2 mg, 0.3653 mmol) in dry THF (7 mL) was added TBAF (730.6 μL, 0.7306 mmol), and the reaction was stirred at room temperature. After 11.5 h, the reaction was quenched adding a sat. NaHCO 3 solution (20 mL) and the mixture was extracted with DCM (3 × 20 mL). The combined organic layers were dried with Na 2 SO 4 and concentrated in vacuo to give the crude product, which was purified by silicagel flash chromatography [2% (10% NH 4 OH in MeOH)/DCM] to provide the product 24 (95.1 mg, 75% (25) . To a stirred solution of 7 (100 mg, 0.4027 mmol), p-TsOH (2.3 mg, 0.1208 mmol), ethylene glycol (450 μL, 8.0540 mmol) in dry DCM (2 mL) was added slowly ethyl orthoformate (301 μL, 1.8121 mmol), and the reaction was stirred at room temperature for 24 h. The reaction was quenched with a sat. NaHCO 3 solution (20 mL) and the aqueous mixture was extracted with DCM (5x20 mL). The combined organic layers were washed with brine (15 mL), dried with Na 2 SO 4 and concentrated in vacuo to give the crude product, which was purified by silicagel flash chromatography (from 10% to 20% EtOAc: Pet.Et. ) to provide the product 25 (113.0 mg, 96% (27) . i) To a stirred solution of 25 (303.8 mg, 1.0398 mmol) and TDMSOTf (465.0 μL, 2.0247 mmol) in dry DCM (10 mL) at 0˚C, was added dry TEA (303.0 μL, 2.1800 mmol) dropwise. The reaction was allowed to reach room temperature and after 3 days, quenched with water (10 mL). Then the mixture was extracted with DCM (3 × 10 mL), dried with Na 2 SO 4 and concentarted in vacuo to give the crude intermediate. ii) The crude of the previous step was dissolved in dry DCM (9 mL) and m-CPBA 77% (233.0 mg, 1.0398 mmol) was added, the reaction was stirred at room temperature for 5 h. The reaction was quenched with a 10% Na 2 S 2 O 3 solution (1 mL), then brine was added (10 mL) and the aqueous mixture was extracted with DCM (4 × 15 mL). The combined organic layers were dried with Na 2 SO 4 and concentrated in vacuo. The product was purified by silicagel flash chromatography (from 15% to 20% EtOAc: Pet.Et. ) to provide the product 27 (233.3 mg, 73% 6α-hydroxyisodamsin (9) . To a solution of 27 (152.1 mg, 0.4932 mmol) in MeOH (5 mL) was added HCl (Conc) (1 mL, 11.6511 mmol) and the reaction was stirred at room temperature. After 4.5 h, the reaction was quenched with sat. NaHCO 3 solution (10 mL) and the aqueous mixture was extracted with DCM (4 × 30 mL). The combined organic layers were dried with Na 2 SO 4 and concentrated in vacuo to give the crude product, which was purified by silicagel flash chromatography (45% EtOAc:Pet.Et. ) to provide the product 9 (94.3 mg, 72% 6 mL) , in a sealed tube was stirred at 120˚C for 4.5 days. After that time the reaction was not complete, therefore a second addition of Pd(OAc) 2 (5.0 mg, 0.0242 mmol), Tri(p-Tolyl)P (29.0 mg, 0.0966 mmol), PhI (81.0 μL, 0.7248 mmol) and Et 3 N (151 μL, 1.0872 mmol) as solution in DMF (1.6 mL) was done. The reaction was stirred for was stirred at 120˚C for 30 h. When the reaction was complete, it was quenched with water (25 mL), and the aqueous mixture was extracted with DCM (5 × 20 mL). The combined organic layers were dried with Na 2 SO 4 and contrated in vacuo to give the crude product, which was purified by silicagel flash chromatography (30% EtOAc:Pet. Et. ) to provide the product 10 (112.0 mg, 57% Cells and luciferase assays. The 5.1 clone line is a Jurkat derived clone stably transfected with a plasmid containing the luciferase gene driven by the HIV-LTR promoter were grown at 37˚C and 5% CO 2 in supplemented RPMI 1640 containing 10% heat-inactivated fetal bovine serum, 2 mM glutamine, penicillin (50 U/mL) and streptomycin (50 μg/mL) and supplemented with G418 (200 µg/m). For the anti-NF-κB activity 5.1 cells were stimulated with TNFα (20 ng/mL) in the presence or the absence of the compounds for six h. The cells were washed twice in PBS and lysed in 25 mM Tris-phosphate pH 7.8, 8 mM MgCl 2 , 1 mM DTT, 1% Triton X-100 and 7% glycerol during 15 min at RT in a horizontal shaker. After centrifugation, the supernatant was used to measure luciferase activity using an Autolumat LB 9510 (Berthold) following the instructions of the luciferase assay kit (Promega, Madison, WI, USA). c) Computational Conformational search calculations for structural elucidation of all the molecules were performed with MacroModel (version 9.9, Schrödinger, LLC, New York, NY, 2011) using the force-field MMFFs, which was generated different conformers for each of molecule. The minimum energy conformer was chosen for full geometry optimization using the ab initio calculations with the basis set B3LYP/6-31G** (Jaguar, version 7.8, Schrödinger, LLC, New York, NY, 2011). The resulting geometries were used for subsequent comparison with the experimental NMR data.
13-cyano-4,4-(ethylenedioxy)-11b,13-dihydro-4-deoxydamsin
1), δ 1.62 (1H, m, H-2a), δ 1.69 (1H, m, H-2b), δ 1.71 (1H, m, H-3a), δ 1.90 (1H, m, H-3b), δ 4.92 (1H, d, 3 J 8.2 Hz, H-6), δ 3.24 (1H, m, H-7), δ 1.66 (1H, m, H-8a), δ 1.97 (1H, m, H-8b), δ 1.59 (1H, m, H-9a), δ 1.78 (1H, m, H-9b), δ 2.02 (1H, m, H-10), δ 6.72 (1H, ddd, 3 J 7.8; 5.5; 2.6 Hz, H-13), δ 1.02 (3H, d, 3 J 7.4 Hz, Me-14), δ 1.11 (3H, s, Me-15), δ 3.13 (1H, dd, 3 J 14.4; 7.7 Hz, -CH a H b N(CH 3 ) 2 ), δ 3.27 (1H, m, -CH a H b N(CH 3 ) 2 ), δ 2.31 (6H, s, -CH a H b N(CH 3 ) 2 ), δ 3.88 (2H, m, -OCH 2 CH 2 O-),
4,4-(ethylenedioxy)-4-deoxyisodamsin

